Pharmaceutical Executive October 22, 2024
The guidelines, titled BRIDGE, are set to be released in 2025.
As more and more pharmaceutical companies are looking to incorporate AI into their processes, it’s becoming clear that there isn’t just one single way to use to technology. Due to its versatility, there are examples of it being added to processes across the entire industry, from everything to marketing, drug development, and even candidate selection.
However, this also makes incorporating the technology much more complicated. Aidoc, a clinical AI company, announced that it has partnered with NVIDIA to develop a blueprint for resilient integration and deployment of guided excellence, otherwise known as BRIDGE.1 The guidelines are set to be unveiled in 2025.
In a press release, Aidoc chief transformation...
Today's Sponsors
Today's Sponsor